"A Trial Tech é uma instituição privada de investigação clínica situada em Curitiba/PR. A instituição oferece suporte em pesquisa clínica a clientes da indústria farmacêutica e CROs (Clinical Trials Organization), atuando na Condução de Estudos Clínicos Fases II, III e IV, com foco nos tratamentos para Alzheimer, Esquizofrenia e Depressão, seguindo rigorosamente o manual de Boa Prática Clínicas (BPC), além das normativas nacionais regulamentadas pelo Conselho Nacional de Saúde, pela Comissão Nacional de Ética em Pesquisa e pela Agência Nacional de Vigilância Sanitária/Ministério da Saúde."

During the past decade, Trial Tech Tecnologia em Pesquisas com Medicamentos conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trial Tech Tecnologia em Pesquisas com Medicamentos" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Institut de Recherches Internationales Servier" with 1 trials sponsored, "Janssen-Cilag International NV" with 1 trials sponsored and "Janssen-Cilag, S.A." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Trial Tech Tecnologia em Pesquisas com Medicamentos" are "Depressive Disorder, Major" (4 trials), "Schizophrenia" (3 trials), "Alzheimer's Disease" (1 trials), "Anhedonia" (1 trials) and "Depressive Disorder, Treatment-Resistant" (1 trials). Many other conditions were trialed in "Trial Tech Tecnologia em Pesquisas com Medicamentos" in a lesser frequency.

Most popular intervention types in "Trial Tech Tecnologia em Pesquisas com Medicamentos" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aticaprant" (2 trials), "BI 425809" (1 trials), "Esketamine" (1 trials) and "Esketamine 28 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Trial Tech Tecnologia em Pesquisas com Medicamentos" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Trial Tech Tecnologia em Pesquisas com Medicamentos". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Trial Tech Tecnologia em Pesquisas com Medicamentos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Trial Tech Tecnologia em Pesquisas com Medicamentos, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".